Study: Sodium Polystyrene Sulphonate is Associated with Increased Risk of GI Adverse Events in Patients with CKD

Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study – Nephrology Dialysis Transplantation (free)

Commentary: Hyperkalemia Drug Again Linked to Adverse GI Events – Renal & Urology News (free)

Related Study: Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated with Sodium Polystyrene Sulfonate (link to abstract and commentary)